Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
4
result was found. Results that relate to
PI3K/AKT signaling pathway
Research progress on the role of PI3K/AKT signaling pathway in benign prostatic hyperplasia and traditional Chinese medicine intervention
Published on
Journal of Mathematical Medicine
2024,37(10):775-785.
11750 times
2244 times
ZHAO Yuanbo
[Z
GAN Decheng
LU Ganggang
LI Shenglong
Benign prostatic hyperplasia
PI3K/AKT signaling pathway
Prostate cells
Traditional Chinese Medicine
Details
Moluodan concentrated pill in the treatment of chronic atrophic gastritis through the TNF/PI3K/AKT signaling pathway
Published on
Journal of Mathematical Medicine
2024,37(11):823-830.
10059 times
1802 times
CHEN Jin
He Linli
GAO Ying
ZHANG Kuan
Moluodan concentrated pill
Chronic atrophic gastritis
TNF/
PI3K/AKT signaling pathway
Molecular mechanism
Details
Research progress in the treatment of simple obesity with traditional Chinese medicine compounds
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2137-2144.
1453 times
218 times
ZHANG Xiali
WANG Zhuo
MI Li
Simple obesity
Traditional Chinese medicine compounding
Research progress
Leptin resistance
Insulin resistance
Gut microbiota dysbiosis
JAK2-STAT3 signaling pathway
PI3K/Akt signaling pathway
Details
Exploring the in vitro anti-tumor effect and mechanism of Rumex chalepensis based on network pharmacology
Published on
Frontiers in Pharmaceutical Sciences
2026,30(1):2-11.
543 times
147 times
GUO Changhong
YAN Guangjun
MIAO Qing
LIU Limei
XU Jing
LIU Chong
WANG Yejing
XIANG Caiqiong
Rumex chalepensis
Network pharmacology
Gastric cancer
PI3K/Akt signaling pathway
Apoptosis
Cell cycle arrest
Multi-target action
Natural anti-tumor drug
Details